• LYON

News / Press


As our lawyers are often at the forefront of developments in IP they author articles, speak at events and are also quoted in the press. For more information, click on the area that interests you.

If you are interested in receiving comment on a particular topic from any of our lawyers please contact Alexandra Coppieters at alexandra.coppieters@hoyngrokh.com or Stefan Didyk at stefan.didyk@hoyngrokh.com.

  • The german office of HOYNG ROKH MONEGIER has been nominated as "Law Firm of the Year for IP" by industry publication JUVE.
  • HOYNG ROKH MONEGIER obtained an important victory for its longstanding client AstraZeneca in relation to AstraZeneca’s breast cancer drug Faslodex (fulvestrant). On 27 July 2016 the PI judge of the District Court of The Hague granted a provisional injunction against Sandoz following an intended generic launch at risk in the Netherlands.
  • On 10 August 2016, the preliminary relief judge of the district court of The Hague issued an injunction against retail giant Lidl that prevents it from selling its latest series of electric shavers, sold under the name Silvercrest.
  • 1. On 23 June 2016 the people of the United Kingdom of Great Britain and Northern Ireland voted in favour of leaving the European Union. This decision, particularly when executed, will undoubtedly affect the economy and the politics of the EU in many different ways that are difficult to predict at this stage.
  • Click here to read a short article by Willem Hoyng published on the EPLAW blog on the fact that "Brexit" does not necessarily mean the end of the UPC.
  • Follow the link to read an interview of Christine Kanz, managing partner of HOYNG ROKH MONEGIER's Dusseldorf office who was interviewed by Managing IP following their list of top 250 female IP practitioners.
  • HOYNG ROKH MONEGIER is ranked second in Who'sWho Legal 2016 IP report.
  • HOYNG ROKH MONEGIER is set to open an office in Munich on 1 September 2016, in addition to the existing offices in Amsterdam, Brussels, Düsseldorf, Madrid, Mannheim (branch office) and Paris. The law firm will thus be represented at seven locations across Europe. As the seat of the German Federal Patent Court, the European Patent Office, and the future seat of the Central Division and the Local Division of the Unified Patent Court, Munich is an important location for matters pertaining to patent law in Germany and Europe. Upon opening, Klaus Haft, partner of HOYNG ROKH MONEGIER will work out of the office in the Bavarian capital for a part of his time. The new office will be located at Theatinerstraße 7 in 80333 Munich.
  • HOYNG ROKH MONEGIER won three Who´s Who Legal Awards during the awards ceremony that was held on 11 April at The University Club in New York. The firm scooped up the following awards: Patent firm of the year, Life Sciences Patent litigation firm and partner Benoît Strowel was honored as lawyer of the year in that same category. Every year Who’s Who Legal issues awards to the individuals and firms that have performed exceptionally well in its research.
  • On April 1, 2016, the U.S. Patent and Trademark Office (USPTO) issued amended rules of practice for Trials before the Patent Trial and Appeal Board (PTAB), including inter partes review (IPR), post-grant review (PGR), covered business method review (CBM), and derivation proceedings. The new rules take effect on May 2, 2016.